Discover how RNA therapeutics are reshaping medicine, offering new treatments for previously undruggable targets.

A new study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable ...

A study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable of ...

Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...

biotechnology companies that produce RNA and mRNA medicines, respectively. More information: Zwitterionic Polymer-Functionalized Lipid Nanoparticles for the Nebulized Delivery of mRNA, Journal of ...

Decades of work have yielded lipid nanoparticle structures that deliver RNA to specific locations in the body. This ...

Lipid nanoparticles (LNPs) play a critical role for mRNA therapies because they protect the nucleic acid material from degradation as it is delivered to the targeted cell. Precise characterization ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer.

The research indicates that Serina’s POZ-lipid, a component of lipid nanoparticles (LNPs), does ... safer LNP formulations for gene therapy and RNA-based medicines. Serina is focused on ...

Learn how nanoparticles cross the blood-brain barrier (BBB) and explore their potential in treating neurological disorders ...